Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats (Q73025967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

N Bouby

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Hassler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

991-1004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

The Elaboration of Osmotically Concentrated Urine in Renal Disease

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Observations on the concentrating and diluting mechanisms of the diseased kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

STUDIES OF EXPERIMENTAL RENAL FAILURE IN DOGS. I. EFFECT OF 5-6 NEPHRECTOMY ON CONCENTRATING AND DILUTING CAPACITY OF RESIDUAL NEPHRONS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Vasopressin is involved in renal effects of high-protein diet: study in homozygous Brattleboro rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and CRF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Contraction of Cultured Rat Glomerular Cells of Apparent Mesangial Origin after Stimulation with Angiotensin II and Arginine Vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Renal microvascular effects of vasopressin and vasopressin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Effects of systemic hypertension, antidiuretic hormone, and prostaglandins on remnant nephrons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Evidence for the involvement of vasopressin in the pathophysiology of adriamycin-induced nephropathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Direct and indirect cost of urea excretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

V2 receptor-mediated vasodilation in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900330-6

10.1016/S0024-3205(99)00330-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10499867%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference